atropine has been researched along with arginyl-glycyl-aspartic acid in 1 studies
Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (arginyl-glycyl-aspartic acid) | Trials (arginyl-glycyl-aspartic acid) | Recent Studies (post-2010) (arginyl-glycyl-aspartic acid) |
---|---|---|---|---|---|
26,711 | 1,259 | 1,697 | 4,556 | 17 | 1,799 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrade-Lopes, AL; de Miranda, A; Farias, EH; Ferreira, AT; Godinho, RO; Justo, GZ; Medeiros, VP; Nader, HB; Paredes-Gamero, EJ; Tersariol, IL; Trindade, ES | 1 |
1 other study(ies) available for atropine and arginyl-glycyl-aspartic acid
Article | Year |
---|---|
Heparin induces rat aorta relaxation via integrin-dependent activation of muscarinic M3 receptors.
Topics: Acetylcholine; Animals; Anticoagulants; Aorta, Thoracic; Atropine; Blotting, Western; Cattle; Cell Line; Dose-Response Relationship, Drug; Endothelium, Vascular; Fluorescence Resonance Energy Transfer; Heparin; In Vitro Techniques; Integrins; Male; Nitric Oxide; Oligopeptides; Paxillin; Protein Binding; Proto-Oncogene Proteins pp60(c-src); Rats; Rats, Wistar; Receptor, Muscarinic M3; Vasodilation; Vasodilator Agents | 2010 |